Clinical Imaging Scientific Director (Oncology)
Regeneron
August 30, 2026
On-site
Tarrytown, NY
Clinical Research and Development
Discover Your Role
- Create fit-for-purpose imaging biomarker strategies to develop imaging endpoints that advance the clinical pipeline.
- Prepare and present clinical imaging strategies to senior management.
- Manage a complex network of stakeholders across the company.
- Lead, design, and implement multi-modality imaging measures as endpoints for oncology therapeutic clinical studies.
- Serve as imaging subject matter expert to ensure optimal design and execution, including protocols, imaging endpoints, imaging manuals/charters, statistical analysis plans, and clinical study reports.
- Partner with Clinical Imaging Operations and imaging CROs to ensure conduct and data integrity of imaging components and endpoints.
- Serve as Study Scientific Director for trials focused on qualification and utilization of novel imaging biomarkers.
- Lead regulatory communications regarding imaging endpoints and procedures.
- Lead regulatory and site ethics committee interactions for approval of clinical imaging biomarker development studies.
This Role Requires
- PhD with 10+ years of clinical imaging experience (7+ years within oncology drug development).
- Superior written/verbal communication and organization skills.
- Experience implementing central efficacy assessments using RECIST 1.1, iRECIST, PCWG3, Lugano, and IMWG in oncology trials.
- Successful regulatory agency engagement; ability to champion imaging innovations and lead projects effectively.
- Experience as Study Scientific Director for PET imaging biomarker clinical trials in Oncology.
- Experience applying PET imaging as a quantitative endpoint in oncology clinical and preclinical studies.
Application Instructions
- Apply now.
- Create fit-for-purpose imaging biomarker strategies to develop imaging endpoints that advance the clinical pipeline.
- Prepare and present clinical imaging strategies to senior management.
- Manage a complex network of stakeholders across the company.
- Lead, design, and implement multi-modality imaging measures as endpoints for oncology therapeutic clinical studies.
- Serve as imaging subject matter expert to ensure optimal design and execution, including protocols, imaging endpoints, imaging manuals/charters, statistical analysis plans, and clinical study reports.
- Partner with Clinical Imaging Operations and imaging CROs to ensure conduct and data integrity of imaging components and endpoints.
- Serve as Study Scientific Director for trials focused on qualification and utilization of novel imaging biomarkers.
- Lead regulatory communications regarding imaging endpoints and procedures.
- Lead regulatory and site ethics committee interactions for approval of clinical imaging biomarker development studies.
This Role Requires
- PhD with 10+ years of clinical imaging experience (7+ years within oncology drug development).
- Superior written/verbal communication and organization skills.
- Experience implementing central efficacy assessments using RECIST 1.1, iRECIST, PCWG3, Lugano, and IMWG in oncology trials.
- Successful regulatory agency engagement; ability to champion imaging innovations and lead projects effectively.
- Experience as Study Scientific Director for PET imaging biomarker clinical trials in Oncology.
- Experience applying PET imaging as a quantitative endpoint in oncology clinical and preclinical studies.
Application Instructions
- Apply now.